Neha Kharod, MD
Allergy & Immunology · Pooler, GANPI 1851520019
Payments from drug & device makers
Across 77 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$511
- AstraZeneca$146
- Novartis$91
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$83
- Regeneron Healthcare Solutions, Inc.$70
- ARS Pharmaceuticals Operations, Inc.$58
- plus $587 from 21 others
What the payments were for
- Food & beverage$1,547100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 25 | $511 |
| AstraZeneca | 8 | $146 |
| Novartis | 4 | $91 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $58 |
| Bayer | 2 | $51 |
| Novo Nordisk | 3 | $48 |
| Abbott | 2 | $48 |
| Johnson & Johnson | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $34 |
| Lilly USA, LLC | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Greer Laboratories, Inc. | 1 | $32 |
| Sanofi | 1 | $26 |
| Phadia US Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Pfizer | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Alk-abello, Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Kaleo, Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Ionis Pharmaceuticals, Inc. | 1 | $15 |
| Grifols USA, LLC | 1 | $14 |
How this compares
$1,547 in reported general payments places this provider in the 25th percentile of 107 allergy & immunology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyzine Hcl | 25 | $513 |
| Montelukast Sodium | 13 | $148 |
| Prednisone | 15 | $18 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Pooler
- Michele HensonPooler$14K
- Nathan SegallStockbridge$4.5M
- Tracy BridgesAlbany$1.5M
- Brad GoodmanSavannah$1.3M
- Michael BlaissRoswell$1.1M
- Robert ChrzanowskiColumbus$941K
- Stanley FinemanMarietta$855K
- Robert CartwrightColumbus$678K
- Deborah BirxAtlanta$470K
- Jack EadesMacon$282K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.